While constructing a catalog of mouse cDNAs which are expressed in the maternal-fetal interface during the periimplantation period, we encountered a 1.6 kb cDNA clone showing a strong sequence similarity to the 3′ untranslated region of the human dystroglycan gene. We cloned an additional 1.7 kb cDNA by reverse transcriptase-PCR (RT-PCR) and confirmed that this is a true mouse homolog of human dystroglycan cDNA by sequence analyses, Southern blotting, and genetic mapping of this gene on the distal region of mouse chromosome 9. Although it is well established that dystroglycan, a transmembrane protein, plays an important role in muscle tissues by bridging intracellular dystrophin to the laminin in the extracellular matrix, its role in non-muscle tissues remains elusive. To further investigate the role of the dystroglycan gene at the peri-implantation stage, we analyzed the expression patterns of this gene by in situ hybridization, which revealed that this gene is specifically expressed in decidual cells, especially in the cells surrounding the implantation site at 6.5, 7.5, and 8.5 day post conception (p.c.) stages, but not expressed in non-pregnant endometrial cells of uterus nor in the decidua at 12.5 day p.c. Further analyses by RT-PCR confirmed that the amount of dystroglycan mRNA in 8.5 day p.c. decidua was indeed 100-fold higher than that of non-pregnant uterus and 12.5 day p.c. mature placenta. These results suggest that dystroglycan may work as a mediator for adhesion between decidual cells themselves or between decidual cells and trophoblast cells, and provide a structural and functional support for maintaining pregnancy at its early stage.
INTRODUCTION
Dystroglycan is one of the dystrophin-associated glycoproteins, which is encoded by a 5.5 kb transcript in human (1) . The protein product is cleaved into two non-covalently associated subunits, α (N-terminal) and β (C-terminal). In skeletal muscle the dystroglycan complex works as a transmembrane linkage between the extracellular matrix and the cytoskeleton (1) . α-dystroglycan is extracellular and binds to merosin (α-2 laminin) in the basement membrane, while β-dystroglycan is a transmembrane protein and binds to dystrophin, which is a large rodlike cytoskeletal protein, absent in Duchenne muscular dystrophy patients (2) . Dystrophin binds to intracellular actin cables. In this way, the dystroglycan complex, which links the extracellular matrix to the intracellular actin cables, is thought to provide structural integrity in muscle tissues. The dystroglycan complex is also known to serve as an agrin receptor in muscle, where it may regulate agrin-induced acetylcholine receptor clustering at the neuromuscular junction (3). There is also evidence which suggests the function of dystroglycan as a part of the signal transduction pathway because it is shown that Grb2, a mediator of the Ras-related signal pathway, can interact with the cytoplasmic domain of dystroglycan (4) . In general, aberrant expression of dystrophin-associated protein complex underlies the pathogenesis of Duchenne muscular dystrophy, Becker muscular dystrophy and severe childhood autosomal recessive muscular dystrophy (5-7). Interestingly, no genetic disease has been described for either α-or β-dystroglycan (2) .
Dystroglycan is widely distributed in non-muscle tissues as well as in muscle tissues (8) . During epithelial morphogenesis of kidney, the dystroglycan complex is shown to act as a receptor for the basement membrane (9) . Dystroglycan expression in mouse brain (10) and neural retina (11) has also been reported. However, the physiological role of dystroglycan in non-muscle tissues has remained unclear.
While working on a large scale sequencing project on the cDNA library made from the ectoplacental cone (EPC) of the 7.5 day post conception (p.c.) mouse embryos, we encountered a cDNA clone which shows significant sequence similarity to the 3′-untranslated region (UTR) of the human dystroglycan gene. We were intrigued by the unexpected expression of the dystroglycan gene at the peri-implantation stage and decided to examine this in more detail. Because of the well-established function of dystroglycan as the cell adhesion molecule to the extracellular matrix (5) (6) (7) , it is tempting to speculate that dystroglycan plays a new role in the embryo implantation site. It has been reported that several cell adhesion molecules and extracellular matrix molecules such as P-cadhelin (12), α 5 -integrin (13) , osteopontin *To whom correspondence should be addressed (2ar) (14) , laminin (15) , collagen type IV (16, 17) , and heparan sulphate proteoglycan (18) play a role in trophoblast-uterine adhesion. However, it is not clear how many of these molecules are actually related to embryo adhesion (19, 20) . Therefore, the discovery of a new molecule in the maternal-fetal interface may provide a crucial information about how the embryo stably implants in the uterus.
The dystroglycan gene was first cloned from the rabbit based on partial amino acid sequences (8) . The complete human cDNA was also cloned by screening a human skeletal muscle cDNA library with the rabbit cDNA probe (1) . Although partial sequences of cDNA were cloned from the mouse by reverse transcriptase-PCR (RT-PCR) based on the human and rabbit cDNA sequence information (10, 21) , the most important cytoplasmic C-terminal region has not been cloned yet from the mouse.
Here we report the cloning of the missing part of the mouse dystroglycan gene, which covers the β-dystroglycan and the complete 3′-UTR, and the fine localization of the gene on the mouse genetic map. We also show a specific expression pattern of the mouse dystroglycan gene in the implantation site by in situ hybridization and RT-PCR. The new role of dystroglycan in the implantation site will be discussed.
RESULTS

Cloning and sequence analysis of mouse dystroglycan cDNA
We microdissected the EPC from the 7.5 day p.c. mouse embryos and constructed a cDNA library. We picked approximately 5 000 cDNA clones from this library, arrayed them in 96-well microtiter plates, and sequenced the 5′-and 3′-end of randomly chosen cDNAs. About 500 bp of sequence information was obtained from both 5′-and 3′-end of individual cDNA clones. When we did similarity searches of those sequences against the public database with the BLAST program (22), we found that a cDNA clone designated as C0002E12 with a 1.6 kb insert showed a very high homology to the 3′-UTR of the human dystroglycan gene (HUMDAG1) (Fig. 1 ). There were no matched sequences from the mouse. By a key word search of the Genbank database, we found that parts of the mouse dystroglycan gene have already been cloned by RT-PCR based on the human and rabbit dystroglycan sequences (Fig. 1) . One entry (MMDYSGLY) covers 0.9 kb sequence from a part of α-dystroglycan (10), while the other entry (MMRNADAG1) covers 2.0 kb sequence from the complete α-dystroglycan coding region (21) (Fig. 1) .
To clone the missing part of the mouse dystroglycan gene, we designed an upstream primer from the 3′ end of MMRNADAG1 and a downstream primer from the 5′ end of our cDNA sequence ( Fig. 1, arrows; Fig. 2, dotted line) . The single-stranded cDNA mixture from 8.5 day p.c. mouse decidua was amplified with this primer pair. We successfully recovered 1.7 kb cDNA fragment designated as GAP, which now fills the gap between our cDNA clone (C0002E12) and MMRNADAG1. We sequenced the complete C0002E12 and GAP clones (Fig. 2) . Sequence comparisons among human (1), rabbit (8) , and mouse revealed a very strong sequence conservation in the β-dystroglycan-coding region (86.3% similarity between mouse and rabbit, 87.0% similarity between mouse and human). The most 3′ end of the 3′-UTR, which is covered by the clone C0002E12, is relatively well conserved between human and mouse (77.9% similarity), while the 5′ end of the 3′-UTR, which is the upstream part of the clone C0002E12, is more conserved (89.3% similarity). In this most conserved region, we found an 8 bp inverted repeat from 997 bp to 1004 bp and 1017 bp to 1024 bp and a 16 bp inverted repeat from 1376 bp to 1391 bp and from 1439 bp to 1454 bp (Fig.  2) . These inverted repeats have a potential to form stable stem loop structures and might be involved in regulation of expression. Figure 3 shows the comparison of the deduced amino acid sequences from the β-dystroglycan coding region among mouse, human (1), rabbit (8) , and Torpedo (23) . A strong amino acid sequence similarity was observed between the mouse and human (93.8%), and between the mouse and rabbit (94.9%). The potential asparagine-linked glycosylation sites, transmembrane domain, and cytoplasmic proline-rich regions are well conserved (Figs 2, 3) . The cleavage site of the human α-and β-dystroglycan between Gly653 and Ser654 (23) and the intrachain disulfide bond between Cys669 and Cys713 of the human β-dystroglycan (23) are also conserved in the mouse sequence. The amino acid sequence, YRKKRKGK, may be a putative cytoplasmic transmembrane anchor (Figs 2, 3 ).
Fine localization of the dystroglycan gene on the mouse genetic map
To confirm that two cDNA fragments are from the true dystroglycan gene, we mapped the most 3′ end cDNA fragment (C0002E12) on the mouse genetic map as a bEST marker (24) . A PCR primer pair was designed from the sequence (see Fig. 1 ), used to amplify the genomic DNAs of C57BL/6J and M. spretus, and also to sequence the resulting PCR products. We compared the genomic sequence of C57BL/6J and M. spretus and identified a restriction fragment length polymorphism (RFLP) (Fig. 4A) . The gene location was determined by genotyping the Jackson Laboratory's interspecific backcross mouse panel [(C57BL/6JEi × SPRET/Ei) F1 × SPRET/Ei] (25). As shown in Figure 4 , the segregation pattern of the alleles localizes gene on the distal region of mouse chromosome 9. The locus was named D9Wsu13e. Because this result is compatible with the previous mapping results using primer pairs designed from a rabbit cDNA (10) and a human cDNA (26) (see Fig. 1 ), we conclude that the cDNA fragment (C0002E12) is a true mouse homolog of the human dystroglycan gene. Therefore, this locus (D9Wsu13e) was renamed to Dag1. 
Decidua-specific expression of dystroglycan gene by in situ hybridization
To examine the localization of the mRNA of dystroglycan in mouse embryos at the peri-implantation stage, we performed in situ hybridization with digoxigenin-labeled 1.6 kb insert of clone C0002E12. The uniqueness of this probe was checked by Southern blot analysis of mouse genomic DNA using the insert of C0002E12 clone as a probe. Either one major band ( Both sense and anti-sense probes for in situ hybridization were prepared by in vitro transcription. No hybridization signal was observed with the sense probe at any stage of development. At 6.5 day p.c., decidual cells surrounding the EPC and the embryo showed a strong hybridization signal. The signal has a polarity and is mainly seen in the decidual tissue adjacent to the EPC ( Fig.  6a and b) . At 7.5 day p.c., the signal was also detected in decidual cells immediately adjacent to the trophoblast cells ( Fig. 6c ) and in antimesometrial secondary decidual zone (data not shown). At 8.5 day p.c., the hybridization signal was observed in decidua, especially in the mesometrial decidual zone and antimesometrial secondary decidual zone (Fig. 6e) . The expression of dystroglycan seemed to be increasing through 6.5, 7.5 and 8.5 day p.c. in the decidua. In contrast, there was no hybridization signal in non-pregnant uterus and 12.5 day p.c. decidua, when they no longer surround the embryo (data not shown).
Although the clone C0002E12 was obtained from the library made from the EPC at 7.5 day p.c., expression of the dystroglycan gene was not detected in the EPC by in situ hybridization. Because the trophoblast cells, which consist of the EPC, are derived from the conceptus, and the decidual cells are maternal tissue, it is very important to distinguish these two cell types for gene expression analyses. Since the H19 gene is known to be specifically expressed in the trophoblast, not in the decidua at this stage (27) , we decided to use this gene as a control for in situ hybridization. The hybridization signal was indeed observed in the EPC and trophoblastic giant cells (Fig. 6f) . Because the expression pattern of the H19 gene contrasted with that of the dystroglycan gene ( Fig. 6e and f) , we conclude that the dystroglycan is expressed mainly in the decidua, a maternal tissue.
Because dystroglycan is known to colocalize with laminin in the kidney of the 14 day p.c. embryo (9), we examined whether laminin is localized in the decidua at the peri-implantation stage. Immunohistochemistry of tissue sections of 7.5 day p.c. embryo with anti-laminin antibody showed a positive staining in decidual cells (Fig. 6d, arrow) as well as in Reichert's membrane (Fig. 6d,  asterisk) . These data clearly indicate co-localization of dystroglycan and laminin. It is worth noting that laminin is localized ubiquitously in the decidua while dystroglycan is localized only in the part of decidua which borders on the embryo. This suggests that the up-regulation of the dystroglycan gene is not a general feature of decidualization of uterine stroma, but may be related to the embryo.
Decidua-specific expression of dystroglycan gene by RT-PCR
To further examine the decidua-specific expression of the dystroglycan gene, we performed RT-PCR analyses on non-pregnant uterus, decidua at 6.5, 7.5, 8.5, 10.5 day p.c., and 12.5 day p.c. placenta including decidua (Fig. 7A) . Although the expected size of PCR products was detected in all samples, there was a clear gradient of expression levels from the dystroglycan gene. After implantation, expression of the gene gradually increased, peaked at 8.5 day p.c., and decreased at 10.5 day p.c. Limiting dilution PCR analyses showed that the expression level of the dystroglycan gene in 8.5 day p.c. decidua is approximately 100-fold higher than those of non-pregnant uterus and 12.5 day p.c. placenta (Fig. 7B) . No PCR product was observed in all of the samples assayed without reverse transcriptase treatment (data not shown).
DISCUSSION
Although partial sequences of the mouse dystroglycan gene, which cover the N-terminal α-dystroglycan, were already reported (10, 21) , sequence information from the mouse C-terminal β-dystroglycan and the 3′-UTR has not been reported yet. In this paper, we have reported a total 3170 bp of new sequence from the 3′-end of mouse dystroglycan cDNA which covers the missing sequence. With this additional information in hand, we have performed a sequence comparison between the human, rabbit, mouse and a part of the Torpedo sequence. Dystroglycan sequences in these different species are very well conserved, especially in the putative functional domains such as cleavage site between α-and β-dystroglycan (23), the intrachain disulfide bond in β-dystroglycan (23) and C-terminal proline-rich domain in β-dystroglycan which may bind to Grb2 (4) and to dystrophin (28) . These conservations of the sequences suggest the importance of these peptide regions and further support the previously proposed functional domains of the dystroglycan gene. Although it is known that the dystroglycan gene is widely expressed (8), we have presented two types of evidence in this paper for the specific function of this gene in the decidua at the peri-implantation stage. The first evidence is the unique expression pattern of the gene, revealed by in situ hybridization and RT-PCR analyses. Because the expression of the dystroglycan gene in the non-pregnant uterus could not be detected by in situ hybridization and was very low by RT-PCR analysis, the gene must be activated after implantation. At 6.5 day p.c., immediately after implantation, the gene starts to be expressed in the decidua, especially in the region which surrounds the embryo. Expression could not be detected in other regions such as embryonic tissues and extraembryonic tissues including trophoblast cells at this stage by in situ hybridization. As the embryo grows, expression of the dystroglycan gene sharply increases in the same region of decidua until 8.5 day p.c. RT-PCR analysis showed that the expression level of the gene at 8.5 day p.c. was approximately 100-fold higher than that of the non-pregnant uterus. Although the embryo continues to grow, the expression of the dystroglycan gene in the decidua starts to decrease around 10.5 day p.c. At 12.5 day p.c., the expression of the gene in the decidua could no longer be detected by in situ hybridization and was very low by RT-PCR analysis. There are gross functional and anatomical differences between the decidual tissues before and around 8.5 day p.c. and those after 10.5 day p.c. Until around 8.5 day p.c., the embryo is fully surrounded by thick decidual tissues, while the embryo at 12.5 day p.c. is no longer surrounded directly by decidual tissues. By this time, the mature placenta is formed and the placental blood circulation has already been established. These changes start around 10.5 day p.c. The positive correlation between the expression level of the dystroglycan gene and the extent of anatomical and functional dependence of mouse embryos on the decidual tissues strongly suggest that dystroglycan is playing an important role in the decidual tissues adjacent to the implantation site.
Further evidence for the specific role of dystroglycan is the coexpression of dystroglycan and laminin in the decidual cells. Because the decidualization of stromal cells is characterized by the accumulation of pericellular basement membrane materials such as laminin, entactin, fibronectin, type IV collagen, and heparan sulfate proteoglycan (18) , it makes sense to see co-localization of dystroglycan, which is known to bind to laminin (9) . Interestingly, endometrial stromal cells in the non-pregnant uterus, which are the direct precursor of decidual cells in the pregnant uterus, are not surrounded by pericellular matrix and do not produce detectable amounts of basement membrane material in situ (18) . Because we have shown that the expression level of the dystroglycan gene is very low in the non-pregnant uterus, the expression of the laminin gene in the decidua occurs simultaneously with that of the dystroglycan gene. In addition, co-localization of dystroglycan and laminin has already been reported in the cardiac muscle immunohistochemically (29) and in the embryonic kidney by in situ hybridization (9) . In the embryonic kidney, it has been proposed that the dystroglycan is playing an important role by acting as a receptor for basement membrane components during epithelial morphogenesis (9) .
What is the role of dystroglycan in the maternal decidua at the peri-implantation stage? The most reasonable hypothesis is that the dystroglycan is helping to maintain the early pregnancy at the peri-implantation stage by providing a structural support between decidual cells or between decidual cells and trophoblast cells. This idea is based on the current consensus about the function of the dystroglycan to link the intracellular actin cables to the extracellular matrix by binding to utrophin (or dystrophin in muscle tissues) inside the cells and to laminin outside the cells (5-7). This mechanism would provide a structural strength for the decidual tissues and can be used to mediate the adhesion of the embryo to the implantation site within the uterus. Rapid intrauterine growth of the embryo at this stage may require such a supportive mechanism to maintain pregnancy. Co-localization of laminin and dystroglycan in the decidual tissues adjacent to the implantation site supports the hypothesis. It has been suggested that integrins, which are transmembrane proteins expressed in the trophoblast, are the primary molecules to bind the embryo to the uterus, because the integrins can bind to the laminin in the decidua (19, 20) . However, recent experiments using mice with a null mutation in the gene encoding β1 integrin show that the trophoblast can attach to epithelial cells of the uterus and induce the decidual response even in the absence of the β1 integrin (30, 31) , which indicates that β1 integrins are not essential for initial implantation of the embryo. Therefore, dystroglycan can be one of the primary candidates for the adhesion mechanism during implantation.
On the other hand, denser localization of the dystroglycan especially in the mesometrial decidual zone immediately adjacent to the EPC may suggest that dystroglycan, together with laminin, may take part in a protective role for the decidua against trophoblast invasion. Because of their highly invasive nature, human and rodent trophoblasts are often compared to metastatic cells (19) . In fact, mouse embryos transplanted to an ectopic site invade uncontrollably (20, 32) . Although it is suggested that decidual factors may control trophoblast invasion (20, 32, 33) , only a few molecules such as tissue inhibitors of metalloproteinases (TIMPs) are considered as candidates (34, 35) , but no definitive molecule with such a function has been yet identified. Because of its unique expression patterns and functions, dystroglycan will be a good candidate for such a molecule.
A third possibility is that the dystroglycan is working as a mediator of signals between the decidua and trophoblasts, although this does not exclude the two possibilities mentioned above. The function of the dystroglycan as a part of the signal transduction pathway has already been suggested because the Grb2, a mediator of the Ras-related signal pathway, can interact with the cytoplasmic domain of dystroglycan (4) . Establishment of the maternal-fetal interaction in the implantation site may require intimate communication between these two tissues through both the signal transduction pathway and their physical connections, although there has been no direct evidence which suggests the existence of such a mechanism. Alternatively, the signal may suppress the unlimited growth or the invasion of trophoblast cells by modifying the control pathway of cell cycle and cell growth.
Although most of the genes which are involved in the dystrophin complexes have been identified for corresponding genetic diseases (5-7), dystroglycan is one of the genes whose pathological conditions are not known (2) . It is suggested that the classical mouse mutants, tippy (tip) and ducky (du), are good candidates for diseases caused by a mutation in the dystroglycan gene, because the gene has been mapped in the vicinity of those mutant loci and those mutants have defects in the neuro-muscular system (10). However, our new genetic mapping result may suggest that tip and du are not close enough to the dystroglycan gene on the map (Fig. 4) . If the major function of the dystroglycan gene lies in the maternal decidua at the peri-implantation stage, the defects of this gene would not cause developmental defects, but would cause repeated pregnancy loss, which is a difficult subject to pursue genetically. This might be the reason that mutants of this gene have not been found so far. There have been a number of studies which identified causes of the female infertility (36) . For example, half of human embryos are lost during the very early stage of development such as pre-and peri-implantation periods (37) . Although chromosomal aneuploidy is one of the major causes of early embryo loss, there must be causes which have not been identified yet. Defects in the dystroglycan gene might be one of them. It would be interesting to look for mutations in the dystroglycan gene in female patients who suffer from repeated pregnancy loss.
Another important pathological condition related to implantation is pre-eclampsia, which is known as gestational proteinuric hypertension and thought to be caused by the insufficient invasion of trophoblast into the uterine stroma (19, 20) . This is a relatively common complication of pregnancies, whose occurrence is in the range of 2-4% of all pregnancies in the United States (38) and the United Kingdom (39) . Because dystroglycan is likely to be involved in the regulation of trophoblast invasion as we have discussed above, this may be a candidate gene for pre-eclampsia. An exclusion map for pre-eclampsia has been already made from the genetic analyses of 35 families based on the assumption of autosomal recessive inheritance (40) . The results indicate that the pre-eclampsia gene may lie on one of chromosomes 1, 3, 9, or 18. Because the human dystroglycan is mapped to 3p21 (1), it would be interesting to check the linkage between dystroglycan and the pre-eclampsia locus.
MATERIALS AND METHODS
Cloning and sequencing
Construction of the cDNA library and a large scale cDNA sequencing project will be described elsewhere. For the cloning of the GAP clone, total RNA was extracted from the decidual tissues of a single 8.5 day p.c. mouse embryo by Micro RNA Isolation Kit (Stratagene). First-strand cDNA was synthesized from 1 µg of total RNA using an oligo(dT) primer by superscript II RNaseH -reverse transcriptase (Gibco/BRL). One-tenth of the reaction mixture was used as a template for PCR amplification (Expand Long Template PCR System, Boehringer Mannheim) with the primer pair, 5′-TGACATTCACAAGAAAATTGCT-3′ [nucleotide positions 804-825 in ref. (10) ] and 5′-AC-CTAGGTTGGAGGCCATAG-3′. The PCR amplification was performed on a Thermal Cycler Model 9600 (Perkin-ElmerCetus) according to the manufacturer's protocol. PCR product was cloned into pCR-Script SK(+) vector (Stratagene). Cycle sequence reactions were carried out using Taq DyeDeoxy Terminators (Applied Biosystems), and the samples were run on a Model 373A DNA Sequencer (Applied Biosystems). Sequence similarity searches were performed by the BLAST program against the non-redundant sequence database in the National Center for Biotechnology Information (22) . The amino acid sequence was deduced from the nucleotide sequence and analyzed by GenetyxMac 7.3 program (Software Development Co.).
Genomic Southern hybridization
Ten µg of genomic DNA from C57BL/6J mouse were digested by HindIII, BamHI, EcoRI, PstI and PvuII respectively. After gel electrophoresis on 0.8% agarose, the DNAs were blotted onto GeneScreen Plus nylon membrane (DuPont). The membrane was prehybridized in 1% SDS, 1 M sodium chloride, and 10% dextran sulfate for 15 min at 65_C. Hybridization was performed overnight at 65_C with a random-primed [α-32 P]dCTP (Amersham)-labeled DNA probe and 100 µg/ml denatured salmon sperm DNA. The probe was a 1.6 kb insert of clone C0002E12 shown in Figure 2 . The membrane was washed under highstringency conditions; twice in 2× SSC at room temperature for 5 min, twice in 2× SSC and 1.0% SDS at 65_C for 30 min, twice in 0.1× SSC at room temperature for 30 min.
In situ hybridization
Both sense and anti-sense single-stranded RNA probes were synthesized from linearized plasmids: clone C0002E12 for dystroglycan, and clone C0002E06 for H19 (nucleotide positions 789-1899 in ref. 27 ) in the presence of digoxigenin-UTP (Boehringer Mannheim). In situ hybridization was carried out as described (41) with some modifications. In brief, embryos were dissected from C57BL/6J uterus at 6.5, 7.5, 8.5, 10.5, and 12.5 day p.c. The embryos were fixed with 4% paraformaldehyde and embedded in paraffin. Sections were cut from the embryos at 6 µm thickness and mounted on Vectabond (Vector Laboratories) coated slides. The sections were deparaffinized with xylene and rinsed with ethanol. After incubation with 20 µg/ml proteinase K in TE (pH 8.0) for 20 min at 37_C, sections were refixed in 4% paraformaldehyde in PBS for 20 min at 4_C. After washing with PBS, they were treated with freshly made 0.1% sodium borohydride in PBS for 5 min, rinsed in 0.1 M triethanolamine (pH 8.0) for 5 min, and acetylated in the same buffer containing 0.5% acetic anhydride for 10 min. Hybridization was performed in a mixture of 5× SSC (pH 4.5), 50% deionized formamide, 50 µg/ml E.coli tRNA, 50 µg/ml heparin, and 1% SDS. The tissue sections were incubated overnight at 45_C in the hybridization mixture containing the digoxigenin-labeled RNA probe (1 µg ml). After hybridization, the slides were washed in 50% formamide, 5× SSC (pH 4.5), and 1% SDS at 45_C twice for 30 min and treated with 25 µg/ml RNaseA in 0.5 M NaCl, 10 mM Tris-HCl (pH 7.5), and 0.1% Tween-20 for 30 min at 37_C. The slides were then washed in 50% formamide and 5× SSC (pH 4.5) at 45_C twice for 30 min. Hybridization was detected with alkaline phosphatase-conjugated anti-digoxigenin antibody followed by reaction with NBT and BCIP (Boehringer Mannheim). In all specimens, adjacent sections were hybridized with both antisense and sense probes. The specificity of the hybridization was tested by comparing the intensities of reaction color products between each pair of sections.
Immunohistochemical staining
Embryos were fixed with 4% paraformaldehyde and embedded in paraffin. Sections were cut from the embryos at 6 µm thickness and mounted on Vectabond coated slides. The sections were deparaffinized with xylene. They were pretreated with or without 0.1% trypsin in PBS at room temperature for 30 min. Endogenous peroxidase was quenched with 0.3% H 2 O 2 for 20 min. After blocking with 1% bovine serum albumin in PBS, the sections were incubated with affinity-purified rabbit anti-mouse laminin antibody raised against mouse EHS sarcoma (EY Laboratories, INC.) at 4_C overnight. The antibody was diluted 1:50 to 1:200 in PBS before use. Bound antibody was detected using the LSAB kit (DAKO Corp.) using aminoethylcarbazole as peroxidase substrate (red color in the photographs). The sections were counterstained with Meyer's hematoxylin.
RT-PCR
Total RNAs were isolated from non-pregnant uterus, decidua at 6.5, 7.5, 8.5, 10.5 day p.c. and placenta at 12.5 day p.c. by Micro RNA Isolation Kit (Stratagene). cDNAs were synthesized from 1.2 µg of each RNA sample using oligo(dT) by superscript II RNase Hreverse transcriptase (Gibco/BRL). The PCR was carried out for 25 cycles. A reverse transcriptase-free control study was performed simultaneously to exclude the possibility of the contamination with genomic DNA. The dystroglycan primer sequences are 5′-CATG-TAGAGGAGGCAGGC-3′ and 5′-TGGCTCTCTGTCTCAGA-GTCTG-3′. β-actin was used as the internal standard. The β-actin primer sequences are 5′-CCCAACTTGATGTATGAAGG-3′ and 5′-TTGTGTAAGGTAAGGTGTGC-3′. Expected PCR product sizes are 151 bp and 119 bp respectively. For the limiting-dilution PCR analyses, synthesized cDNAs were sequentially diluted in 10-fold steps from 1 to 10 5 and amplified for 30 cycles. The PCR products were electrophoresed on 2% agarose gel, stained with ethidium bromide, and photodocumented on a UV transilluminator.
Mapping
Gene mapping by using interspecific backcross mouse panels between C57BL/6J and Mus spretus was performed as described (42) . A PCR primer pair used for genotyping was the same as that used for RT-PCR analysis described above.
